Health Care: Drugs

Regeneron Pharmaceuticals Inc (REGN: NASDAQ)

$350.455 3.535 | 1.02%
08/29/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 2.10B 1.38B 445.82M 459.07M
Cost of Sales 114.15M 47.52M 4.22M 2.09M
Gross Operating Profit 1.99B 1.33B 441.61M 456.98M
Selling, General, and Administrative Expenses 329.42M 210.76M 117.26M 65.20M
Research & Development 859.95M 625.55M 529.51M 489.25M
Operating Income before D & A (EBITDA) 801.23M 494.65M -205.16M -97.47M
Depreciation & Amortization 41.20M 36.94M 31.08M 19.69M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -231.00K 2.01M 3.55M 2.12M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 759.80M 459.72M -232.69M -115.04M
Interest Expense 46.44M 45.30M 21.28M 9.12M
Pre-Tax Income 713.36M 414.42M -253.97M -124.16M
Income Taxes 289.00M -335.85M -1.13M 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 424.36M 750.27M -221.76M -104.47M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 424.36M 750.27M -221.76M -104.47M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 424.36M 750.27M -221.76M -104.47M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
424.36M 750.27M -221.76M -104.47M
Preferred Dividends
Net Income Available To Common 424.36M 750.27M -221.76M -104.47M
Basic EPS from Continuing Ops. 4.33 7.92 -2.45 -1.26
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 4.33 7.92 -2.45 -1.26
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 4.33 7.92 -2.45 -1.26
Basic Normalized Net Income/Share 4.33 7.92 -2.45 -1.26
EPS fr Continuing Ops. 3.81 6.50 -2.45 -1.26
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 3.81 6.50 -2.45 -1.26
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.25 0.00 0.00
EPS, Total 3.81 6.75 -2.45 -1.26
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
3.81 6.50 -2.45 -1.26
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with REGN

Latest REGN Headlines from TheStreet

More Financial News for REGN

Press Releases for REGN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter